Lewis L. Lanier

Biography

Professor Lewis Lanier is an American Cancer Society Professor, a Professor and Chairman of the Department of Microbiology and Immunology, and Professor of the Cancer Research Institute at the University of California San Francisco, and Co-Leader of the Cancer, Immunity, and Microenvironment Program of the UCSF Helen Diller Comprehensive Cancer Center. Dr. Lanier received his Ph.D. in Microbiology and Immunology from the University of North Carolina, Chapel Hill. After his postdoctoral studies, first at the Lineberg Cancer Center at the UNC, Chapel Hill and then as a Damon Runyon – Walter Winchell Cancer Research Fellow at the University of New Mexico, he joined the Research & Development Department at the Becton Dickinson Monoclonal Center in Mountain View, California, advancing to Associate Director of Research and was a Becton Dickinson Research Fellow. In 1990, he joined the DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, California, where he advanced to Director of Immunobiology.  In 1999, Dr. Lanier joined the faculty of UCSF School of Medicine in San Francisco. His research group studies Natural Killer (NK) cells, which recognize and eliminate cells that have become transformed or infected by viruses. In recognition of his scientific contributions he was awarded the William B. Coley Award for Distinguished Research in Basic Tumor Immunology from the Cancer Research Institute in New York in 2002. In 2005 he was given the Rose Payne Award for contributions to the field of Immunogenetics by the American Society for Histocompatibility and Immunogenetics, in 2010 he was elected to the US National Academy of Sciences and in 2011 was named a Fellow of the American Academy of Microbiology by the American Society for Microbiology and elected to the American Academy of Arts and Sciences.  He was awarded the 2001 Distinguished Service Award from the American Association of Immunologists and served as President of the American Association of Immunologists (2006-2007). He has published more than 400 scientific articles and is a Senior Editor of the Journal of Experimental Medicine, and has also served on the editorial boards of the Journal of Immunology, Annual Review of Immunology, Immunological Reviews, Tissue Antigens, Human Immunology, Immunogenetics, and Immunity.  Dr. Lanier serves on the Scientific Advisory Board of several pharma and biotech companies and research institutes. Ph.D. (Microbiology and Immunology), University of North Carolina, Chapel Hill.

Research Interest

Business